Cg. Robbins et al., COMBINED EFFECTS OF NITRIC-OXIDE AND HYPEROXIA ON SURFACTANT FUNCTIONAND PULMONARY INFLAMMATION, American journal of physiology. Lung cellular and molecular physiology, 13(4), 1995, pp. 545-550
NO and its derivative ONOO- are potent free radicals that can cause ce
ll damage, especially in the presence of O-2. To determine the potenti
al pulmonary toxicities of nitric oxide (NO) and peroxynitrite (ONOO-)
in vitro, Survanta (2.5 mg/ml) was exposed to ONOO- (0.3-8 mM) in the
presence of two different buffering systems (N-2-hydroxyethylpiperazi
ne-N'-2-ethanesulfonic acid and phosphate buffer) and minimum surface
tension (MST) was determined with an oscillating bubble surfactometer.
Significant increases in MST were seen only with exposure to 8 mM ONO
O-, indicating that in vitro, high concentrations of ONOO- can inhibit
natural surfactant function. The in vivo effects of NO and hyperoxia
were then studied in four groups of newborn piglets ventilated for 48
h with 21% O-2, 100% O-2, 21% O-2 and 100 ppm NO, or with 90% O-2 and
100 ppm NO. Five animals served as an untreated control group. Broncho
alveolar lavage fluid (BAL) obtained at 48 h was subjected to centrifu
gation and the surfactant pellet was reconstituted to 5 mg phospholipi
d/ml. Significant increases in MST were seen in surfactant from piglet
s ventilated with NO and 90% O-2, compared with either untreated contr
ols or piglets ventilated with 21% O-2 for 48 h (P < 0.05, analysis of
variance). Significant increases in neutrophil chemotactic activity (
NCA) of BAL were also found in the NO and O-2 group (P < 0.05), with s
ignificant positive interaction between NO and O-2 found (P < 0.01). T
hese data indicate that inhaled NO, in vivo, in the presence of hypero
xia, causes significant surfactant dysfunction and early evidence of p
ulmonary inflammation. This suggests that NO therapy may exacerbate pu
lmonary O-2 toxicity.